CS logo
small CS logo
City of Hope Medical Center

Duarte, California, United States
Cancer treatment center in Duarte, California
1500 E Duarte Rd, Duarte, CA 91010

About City of Hope Medical Center


"Located just northeast of Los Angeles, City of Hope's main campus bridges innovative science with compassionate patient care. Here, stretched across more than 100 acres in the City of Duarte, lushly landscaped gardens and open spaces surround our leading-edge medical, education and research facilities. City of Hope Duarte cares for patients from prevention through survivorship — using an array of world-class technologies, treatments and services and our expertise in cancers and conditions such as HIV and AIDS-related lymphoma."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
City of Hope Medical Center
328
National Cancer Institute (NCI)
17
Total Rows: 57

Clinical Trials at City of Hope Medical Center


During the past decade, City of Hope Medical Center conducted 258 clinical trials. In the 10-year time frame, 258 clinical trials started and 75 clinical trials were completed, i.e. on average, 29.1% percent of trials that started reached the finish line to date. In the past 5 years, 120 clinical trials started and 42 clinical trials were completed. i.e. 35% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years232321212222434329293131363642421111662216165544886613131515Started TrialsCompleted Trails2015201620172018201920202021202220230204060
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Older Patients With Chronic Myeloid Leukemia
1997-08-01
Completed
18
Low-Dose Total Body Irradiation and Donor Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Patients With Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma
1997-09-01
2002-04-01
Completed
63
Tirapazamine, Carboplatin, and Paclitaxel in Treating Patients With Advanced Malignant Solid Tumors
2000-03-01
2012-07-01
Completed
44
Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer
1999-11-01
Completed
55
Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic Malignancies
2000-12-01
Completed
160
Phase II Trial of Decitabine in Patients With Chronic Myelogenous Leukemia Accelerated Phase Who Are Refractory to Imatinib Mesylate (Gleevec)
2002-07-01
Completed
40
Phase II Trial of Decitabine in Patients With Chronic Myelogenous Leukemia Blast Phase Who Are Refractory to Imatinib Mesylate (Gleevec)
2002-07-01
Completed
40
Phase II Trial of Decitabine in Patients With Chronic Myelogenous Leukemia Chronic Phase Who Are Refractory to Imatinib Mesylate (Gleevec)
2002-07-01
Completed
40

Rows per page:

1–100 of 427

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "City of Hope Medical Center" #1 sponsor was "City of Hope Medical Center" with 328 trials, followed by "National Cancer Institute (NCI)" with 17 trials sponsored, "Children's Oncology Group" with 6 trials sponsored, "Fred Hutchinson Cancer Center" with 5 trials sponsored and "Merck Sharp & Dohme LLC" with 5 trials sponsored. Other sponsors include 62 different institutions and companies that sponsored additional 57 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "City of Hope Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 307 trials as a collaborator, "City of Hope Medical Center" with 5 trials as a collaborator, "California Institute for Regenerative Medicine (CIRM)" with 4 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 4 trials as a collaborator and "National Institutes of Health (NIH)" with 4 trials as a collaborator. Other collaborators include 73 different institutions and companies that were collaborators in the rest 68 trials.
Created with Highcharts 11.1.0Top Leading SponsorsCity of Hope MedicalCenter: 328City of Hope MedicalCenter: 328National CancerInstitute (NCI): 17National CancerInstitute (NCI): 17Children's Oncology Group: 6Children's Oncology Group: 6Fred Hutchinson CancerCenter: 5Fred Hutchinson CancerCenter: 5Merck Sharp & Dohme LLC: 4Merck Sharp & Dohme LLC: 4Astex Pharmaceuticals, Inc.: 3Astex Pharmaceuticals, Inc.: 3Arog Pharmaceuticals, Inc.: 2Arog Pharmaceuticals, Inc.: 2BioAtla, Inc.: 2BioAtla, Inc.: 2Candel Therapeutics, Inc.: 2Candel Therapeutics, Inc.: 2Eureka Therapeutics Inc.: 2Eureka Therapeutics Inc.: 2

Created with Highcharts 11.1.0Top CollaboratorsNational CancerInstitute (NCI): 307National CancerInstitute (NCI): 307City of Hope Medical Center: 5City of Hope Medical Center: 5California Institute forRegenerative Medicine(CIRM): 4California Institute forRegenerative Medicine(CIRM): 4National Heart, Lung,and Blood Institute(NHLBI): 4National Heart, Lung,and Blood Institute(NHLBI): 4National Institutes ofHealth (NIH): 4National Institutes ofHealth (NIH): 4AstraZeneca: 3AstraZeneca: 3Eisai Inc.: 3Eisai Inc.: 3National Institute ofNursing Research(NINR): 3National Institute ofNursing Research(NINR): 3National Institute onAging (NIA): 3National Institute onAging (NIA): 3City of Hope NationalMedical Center: 2City of Hope NationalMedical Center: 2

Clinical Trials Conditions at City of Hope Medical Center


According to Clinical.Site data, the most researched conditions in "City of Hope Medical Center" are "Breast Cancer" (18 trials), "Recurrent Mantle Cell Lymphoma" (16 trials), "Acute Myeloid Leukemia" (15 trials), "Hematopoietic and Lymphoid Cell Neoplasm" (15 trials) and "Myelodysplastic Syndrome" (14 trials). Many other conditions were trialed in "City of Hope Medical Center" in a lesser frequency.

Clinical Trials Intervention Types at City of Hope Medical Center


Most popular intervention types in "City of Hope Medical Center" are "Drug" (254 trials), "Other" (247 trials), "Biological" (152 trials), "Procedure" (126 trials) and "Radiation" (45 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (63 trials), "laboratory biomarker analysis" (60 trials), "Questionnaire Administration" (59 trials), "Quality-of-Life Assessment" (50 trials) and "pharmacological study" (34 trials). Other intervention names were less common.

Clinical Trials Genders at City of Hope Medical Center


The vast majority of trials in "City of Hope Medical Center" are 359 trials for "All" genders, 46 trials for "Female" genders and 22 trials for "Male" genders.

Clinical Trials Status at City of Hope Medical Center


Currently, there are 250 active trials in "City of Hope Medical Center". 4 are not yet recruiting, 121 are recruiting, 124 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 123 completed trials in City of Hope Medical Center, 2 suspended trials, and 28 terminated clinical trials to date.
Out of the total trials that were conducted in City of Hope Medical Center, 176 "Phase 1" clinical trials were conducted, 147 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 86 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 1: 176Phase 1: 176Phase 2: 147Phase 2: 147Not Applicable: 86Not Applicable: 86Phase 3: 16Phase 3: 16Early Phase 1: 8Early Phase 1: 8Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusActive, not recruiting: 124Active, not recruiting: 124Completed: 123Completed: 123Recruiting: 121Recruiting: 121Terminated: 28Terminated: 28Withdrawn: 22Withdrawn: 22Not yet recruiting: 4Not yet recruiting: 4Suspended: 2Suspended: 2Approved for marketing: 1Approved for marketing: 1Enrolling by invitation: 1Enrolling by invitation: 1No longer available: 1No longer available: 1